Output details
15 - General Engineering
Brunel University London
Scalable Technology for the Extraction of Pharmaceutics (STEP): The transition from academic knowhow to industrial reality
This paper is the first in a series addressing the technological readiness of counter-current chromatography instruments to become platform technology for the pharmaceutical industry. In this TSB High Value Manufacturing research programme, four case studies are presented that demonstrate the separation power of the instruments to end-user companies, GSK/Pfizer. The focus then changed to rapid method development, automation, continuous processing and instrument reliability culminating in a further publication (Sutherland et al., J.Chromatogr.A., 1282 (2013) 84) demonstrating a robust 24x7 laboratory instrument capable of processing a kilogram of crude per day.
(Keith Freebairn, Director, Second Generation Process Department, GSK– keith.w.freebairn@gsk.com)